Regarding the pivotal role of Wnt/β-catenin signaling in cancer [17, 18], we hypothesize that PDIA6 may promote tumorigenesis and anticancer drug resistance through activation of the Wnt/β-catenin signaling pathway. The gene discussed is PDIA6; the disease is cancer.